The Food and Drug Administration granted emergency use authorization for a saliva-based testing system that can return accurate results in less than three hours.
The SalivaDirect test is conducted using saliva collected in a container without a swab and has a sensitivity of results similar to nasal swabs, which have been used to test for COVID-19 since the start of the pandemic. The FDA announced its emergency use authorization on Saturday, according to CNN.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.